Hepatitis B virus e antigen in viral persistence

乙型肝炎病毒e抗原在病毒持续存在中

基本信息

  • 批准号:
    9402258
  • 负责人:
  • 金额:
    $ 41.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-20 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

Hepatitis B virus (HBV) can cause severe liver diseases including cirrhosis and hepatocellular carcinoma (HCC). There are approximately 350 million people in the world that are chronically infected by this virus, resulting in 0.5-1 million deaths every year. Most chronic HBV carriers acquired the virus early in life from their infected mothers through vertical transmission. In contrast, patients who acquired HBV from other adults through horizontal transmission will usually develop self-limited acute infection. Why vertical transmission leads to chronic infection whereas horizontal transmission leads to self-limited acute infection is unclear. HBV has a very narrow host range, which has greatly hampered its research. We have recently developed a mouse model to study the maternal effect on HBV persistence in the offspring. By crossing female hemizygous HBV transgenic mice to male naïve mice, we obtained non-transgenic mouse pups. When these non-transgenic mouse pups were injected with the HBV genomic DNA by hydrodynamic injection, the HBV replication persisted in the mouse liver for up to seven months. This is in contrast to control mice born to non-transgenic mothers, which cleared HBV after 3-4 weeks of HBV DNA injection. Our further studies indicated that the maternal HBV e antigen (HBeAg) could condition the Kupffer cells of the offspring, which would undergo M2 polarization to support HBV persistence upon re-stimulation by HBeAg. The goal of this application is to continue these previous studies to further investigate how HBeAg interacts with Kupffer cells. Specifically, we will determine how HBeAg stimulates Kupffer cells and to identify the putative HBeAg receptor in these cells. We will also determine whether HBeAg by itself is sufficient to condition Kupffer cells of the offspring to support HBV persistence and whether Kupffer cells by themselves are sufficient to support HBV persistence. We will also test the hypothesis that HBeAg conditions Kupffer cells in utero to suppress the immune response to HBV in the offspring. Finally, we will study the HBV basal core promoter mutant, which has reduced expression of HBeAg and is associated with chronic hepatitis and an increased risk for HCC, to test whether this reduction of HBeAg expression leads to the partial loss of immune tolerance. The proposed studies will provide important information for us to understand the mechanism of HBV persistence after vertical transmission and to improve the treatments for chronic HBV patients.
B型肝炎病毒(HBV)可导致严重的肝脏疾病,包括肝硬化和肝细胞癌 (HCC)。世界上大约有3.5亿人长期感染这种病毒, 每年造成50 - 100万人死亡。大多数慢性HBV携带者在生命早期从他们的父母那里获得病毒。 通过垂直传播感染的母亲。相比之下,通过以下途径从其他成人获得HBV的患者, 水平传播通常会发展为自限性急性感染。为什么垂直传播会导致 慢性感染,而水平传播导致自限性急性感染尚不清楚。HBV有一个非常 寄主范围窄,这极大地限制了其研究。我们最近开发了一种小鼠模型, 研究母亲对HBV在后代中持续存在的影响。通过杂交雌性半合子HBV转基因 通过将小鼠转化为雄性幼稚小鼠,我们获得了非转基因小鼠幼崽。当这些非转基因小鼠幼崽 通过流体动力学注射将HBV基因组DNA注射到小鼠体内,HBV复制持续存在 肝脏长达7个月。这与非转基因母亲所生的对照小鼠相反, HBV DNA注射后3-4周。我们进一步的研究表明,母亲HBV e抗原 HBeAg可调节子代Kupffer细胞,使其发生M2极化以支持HBV HBeAg再刺激后持续存在。本申请的目的是继续这些先前的研究, 进一步研究HBeAg如何与枯否细胞相互作用。具体来说,我们将确定HBeAg如何刺激 Kupffer细胞,并确定这些细胞中的假定HBeAg受体。我们还将确定HBeAg是否 本身足以调节后代的枯否细胞以支持HBV持续存在, 细胞本身就足以支持HBV的持续存在。我们还将检验HBeAg 条件库普弗细胞在子宫内,以抑制免疫反应的乙肝病毒在后代。最后,我们将研究 HBV基本核心启动子突变体,其具有降低的HBeAg表达,并且与慢性乙型肝炎相关。 乙型肝炎和肝癌风险增加,以测试HBeAg表达的减少是否导致部分 免疫耐受的丧失。建议的研究将为我们了解 HBV垂直传播后持续存在的机制和改善慢性HBV治疗的研究 患者

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J.-H. James Ou其他文献

J.-H. James Ou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J.-H. James Ou', 18)}}的其他基金

Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
  • 批准号:
    10094192
  • 财政年份:
    2020
  • 资助金额:
    $ 41.25万
  • 项目类别:
Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
  • 批准号:
    10334474
  • 财政年份:
    2020
  • 资助金额:
    $ 41.25万
  • 项目类别:
Autophagy and the Replication of Hepatitis B Virus
自噬和乙型肝炎病毒的复制
  • 批准号:
    10549790
  • 财政年份:
    2020
  • 资助金额:
    $ 41.25万
  • 项目类别:
Hepatitis B virus e antigen in viral persistence
乙型肝炎病毒e抗原在病毒持续存在中
  • 批准号:
    10159091
  • 财政年份:
    2017
  • 资助金额:
    $ 41.25万
  • 项目类别:
Hepatitis B virus e antigen in viral persistence
乙型肝炎病毒e抗原在病毒持续存在中
  • 批准号:
    10650689
  • 财政年份:
    2017
  • 资助金额:
    $ 41.25万
  • 项目类别:
2014 International Meeting on the Molecular Biology of Hepatitis B Viruses
2014年乙型肝炎病毒分子生物学国际会议
  • 批准号:
    8712000
  • 财政年份:
    2014
  • 资助金额:
    $ 41.25万
  • 项目类别:
HBV replication and carcinogenesis
乙型肝炎病毒复制和致癌作用
  • 批准号:
    8544645
  • 财政年份:
    2013
  • 资助金额:
    $ 41.25万
  • 项目类别:
HBV replication and persistence in mouse models
小鼠模型中的 HBV 复制和持久性
  • 批准号:
    8598634
  • 财政年份:
    2013
  • 资助金额:
    $ 41.25万
  • 项目类别:
HBV replication and persistence in mouse models
小鼠模型中的 HBV 复制和持久性
  • 批准号:
    8719097
  • 财政年份:
    2013
  • 资助金额:
    $ 41.25万
  • 项目类别:
HBV replication and carcinogenesis
乙型肝炎病毒复制和致癌作用
  • 批准号:
    8899467
  • 财政年份:
    2013
  • 资助金额:
    $ 41.25万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了